Market Research Life Sciences Market Research Diagnostics Market Research In Vitro Diagnostics Market Research Coagulation Market Research

Plasma Fractionation Market Research Report Data by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others), by Method (Cryoprecipitation, Chromatography, Ethanol Precipitation, Ultrafiltration, and Others), by

Best Price Guarantee Length Publisher Published Date SKU
from $4,950 142 Pages Market Research Future July, 2024 RESFT19017791
Best Price Guarantee
Price from $4,950
Length 142 Pages
Publisher Market Research Future
Published Date July, 2024
SKU RESFT19017791

Plasma Fractionation Market Research Report Data by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others), by Method (Cryoprecipitation, Chromatography, Ethanol Precipitation, Ultrafiltration, and Others), by Application (Immunology, Neurology, Hematology, Critical Care, Pulmonology, Rheumatology, Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Industry Forecast to 2030


In 2023, the market size of induction furnaces was estimated to be USD 1919.5 million. The Induction Furnace Market industry is anticipated to experience a compound annual growth rate (CAGR) of 5.32% from USD 2021.23 million in 2024 to USD 3059.6 million by 2032. This growth is expected to occur over the forecast period (2024-2032). In recent years, the Induction Furnace Market has experienced remarkable market growth and is expected to continue to experience significant sales in the foreseeable future due to the consistent increase in demand for energy-efficient and technology-driven solutions. Additionally, the Induction Furnace Market is experiencing further growth due to the substantial demand generated by the steel and aluminum industries and the increasing manufacturing output from manufacturing industries. Additionally, the sales of induction furnaces are being significantly influenced by the substantial penetration of both small-scale and prominent manufacturers of induction furnaces across continents.

The market for induction furnaces is currently undergoing substantial growth, primarily because of the unparalleled accessibility of these cutting-edge metallurgical systems. The landscape of metal manufacturing and processing industries has been entirely transformed by this level of accessibility, resulting in a significant increase in demand for induction furnaces. Induction furnaces have historically been considered the optimal option for businesses in a variety of sectors due to their environmental friendliness, precision, and efficiency. Nevertheless, the current market trend is distinguished by the exceptional accessibility of these furnaces to a diverse array of industries, including agile startups and large-scale enterprises. This accessibility is tremendously advantageous to small and medium-sized enterprises (SMEs).

Market segment insights
The Induction Furnace Market has been segmented into coreless induction furnace and channel induction furnace based on type.
The Market has been segmented into three categories: Up To 1 Ton, 1-100 Ton, and More Than 100 Ton, based on capacity.
The Induction Furnace Market has been segmented into steel, aluminum, copper, and other industries based on end use.

Regional Perspectives
North America, Europe, Asia Pacific, Middle East and Africa, and South America comprise the Induction Furnace Market, which has been segmented by region. The Induction Furnace Market is expected to be driven by the Asia Pacific and Europe regions for the duration of the forecast period. It is anticipated that the target regions will provide a total incremental opportunity of USD 769.4 Mn by the conclusion of 2032. The induction furnace market is experiencing rapid expansion in the Asia Pacific region. The expansion of this market in the region is influenced by a variety of factors. Initially, Asia Pacific is the location of several of the world's largest and fastest-growing industrial sectors, such as electronics production, automotive manufacturing, and steel production.

The induction furnace market in North America is characterized by consistent expansion, which is influenced by a variety of factors. Induction furnaces have been consistently in demand due to the region's robust industrial base, which is notably evident in the aerospace, automotive, and manufacturing sectors. These furnaces are preferred due to their eco-friendly operation, precise temperature control, and energy efficiency. In addition, the growing emphasis on environmental regulations and sustainability has led numerous industries to implement induction furnaces because of their lower energy consumption and emissions in comparison to conventional melting and heating techniques. Furthermore, the ongoing modernization and automation of manufacturing processes have significantly increased the adoption of induction furnace technology. Manufacturers are emphasizing technological advancements and product enhancements to meet the changing needs of the industry, which is also resulting in market innovations.

Major Players
Ajax TOCCO Magnethermic Corporation, Electrotherm Limited, ABP Induction System, Inductotherm Corporation, FOMET, Otto Junker, Tenova SPA, Pioneer Furnaces Pvt.Ltd, Saint-Gobain, Duca Manufacturing, ZZ Industrial (Shanghai) Co., Ltd., Topcast Engineering, Wertli AG, HarbisonWalker International, Marx GmbH & Co. KG, and others are among the major players in the market.


1 Executive Summary
1.1 Overview
1.1.1 Market Synopsis
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
2.5 List Of Assumptions & Limitations
3 Research Methodology
4 Market Dynamics
4.1 Overview
4.2 Drivers
4.2.1 Increasing Demand For Plasma-derived Medicinal Products (Pdmps)
4.2.2 Growing Awareness And Diagnosis Of Rare Diseases
4.2.3 Rising Geriatric Population Across The Globe
4.3 Restraints
4.3.1 Emergence Of Recombinant Therapies As An Alternative To Plasma-derived Medicines
4.4 Opportunity
4.4.1 Growing Technological Advancements And Innovation
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D
5.1.2 Manufacturing
5.1.3 Distribution And Sales
5.1.4 Post-sales Monitoring
5.2 Porter’s Five Forces Model
5.2.1 Threat Of New Entrants
5.2.2 Bargaining Power Of Suppliers
5.2.3 Threat Of Substitutes
5.2.4 Bargaining Power Of Buyers
5.2.5 Intensity Of Rivalry
5.3 Impact Of Covid-19 On The Global Plasma Fractionation Market
5.3.1 Impact On Supply Chain
5.3.2 Impact On Key Players
6 Global Plasma Fractionation Market, By Product
6.1 Overview
6.2 Immunoglobulin
6.2.1 Intravenous Immunoglobulins
6.2.2 Subcutaneous Immunoglobulins
6.2.3 Others
6.3 Coagulation Factor Concentrates
6.3.1 Factor Vii
6.3.2 Factor Viii (Von Willebrand Factor)
6.3.3 Factor Ix
6.3.4 Prothrombin Complex Concentrate
6.3.5 Fibrinogen Concentrates
6.3.6 Factor Xiii
6.4 Albumin
6.5 Protease Inhibitors
6.6 Others
7 Global Plasma Fractionation Market, By Method
7.1 Overview
7.2 Cryoprecipitation
7.3 Chromatography
7.4 Ethanol Precipitation
7.5 Ultrafiltration
7.6 Others
8 Global Plasma Fractionation Market, By Application
8.1 Overview
8.2 Immunology
8.3 Neurology
8.4 Hematology
8.5 Critical Care
8.6 Pulmonology
8.7 Rheumatology
8.8 Oncology
8.9 Others
9 Global Plasma Fractionation Market, By End User
9.1 Overview
9.2 Hospitals & Clinics
9.3 Clinical Research Laboratories
9.4 Academic Institutes
9.5 Others
10 Global Plasma Fractionation Market, By Region
10.1 Overview
10.2 North America
10.2.1 Us
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 Uk
10.3.4 Italy
10.3.5 Spain
10.3.6 Belgium
10.3.7 Rest Of Europe
10.4 Asia-pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Australia
10.4.6 Rest Of Asia-pacific
10.5 Rest Of The World
10.5.1 Middle East
10.5.2 Africa
10.5.3 Latin America
11 Competitive Landscape
11.1 Overview
11.2 Competitive Benchmarking
11.3 Major Growth Strategy In The Global Plasma Fractionation Market
11.4 The Leading Player In Terms Of The Number Of Developments In The Global Plasma Fractionation Market
11.5 Key Development Analysis
11.6 Key Developments & Growth Strategies
11.6.1 Product Approval
11.6.2 Acquisition
11.6.3 Expansion
11.7 Major Players Financial
11.7.1 Sales (Usd Billion), 2
11.7.2 Research & Development Expenditure (Usd Billion), 2
12 Company Profiles
12.1 Pfizer, Inc
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products Offered
12.1.4 Key Developments
12.1.5 Financial Overview
12.1.6 Key Strategies
12.2 Bio Products Laboratory Ltd
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products Offered
12.2.4 Key Developments
12.2.5 Key Strategies
12.3 Kedrion S.P.A
12.3.1 Company Overviews
12.3.2 Financial Overview
12.3.3 Products Offered
12.3.4 Key Developments
12.3.5 Key Strategies
12.4 Adma Biologics, Inc
12.4.1 Company Overviews
12.4.2 Financial Overview
12.4.3 Products Offered
12.4.4 Key Developments
12.4.5 Key Strategies
12.5 Japan Blood Products Organization
12.5.1 Company Overviews
12.5.2 Financial Overview
12.5.3 Products Offered
12.5.4 Key Developments
12.5.5 Key Strategies
12.6 Grifols, S.A.
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products Offered
12.6.4 Key Developments
12.6.5 Swot Analysis
12.6.6 Key Strategies
12.7 Takeda Pharmaceutical Company Limited
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products Offered
12.7.4 Key Developments
12.7.5 Swot Analysis
12.7.6 Key Strategies
12.8 Csl
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products Offered
12.8.4 Key Developments
12.8.5 Swot Analysis
12.8.6 Key Strategies
12.9 Octapharma Ag
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products Offered
12.9.4 Key Developments
12.9.5 Swot Analysis
12.9.6 Key Strategies
12.10 Km Biologics
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products Offered
12.10.4 Key Developments
12.10.5 Key Strategies
13 Appendix
13.1 References
13.2 Related Reports
List Of Tables
Table 1 List Of Assumptions & Limitations
Table 2 Global Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 3 Global Plasma Fractionation Market, For Immunoglobulin, By Region, 2019–2030 (Usd Billion)
Table 4 Global Plasma Fractionation Market, For Immunoglobulin, By Type, 2019–2030 (Usd Billion)
Table 5 Global Plasma Fractionation Market, For Intravenous Immunoglobulins By Region, 2019–2030 (Usd Billion)
Table 6 Global Plasma Fractionation Market, For Subcutaneous Immunoglobulins, By Region, 2019–2030 (Usd Billion)
Table 7 Global Plasma Fractionation Market, For Others, By Region, 2019–2030 (Usd Billion)
Table 8 Global Plasma Fractionation Market, For Coagulation Factor Concentrates, By Region, 2019–2030 (Usd Billion)
Table 9 Global Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 10 Global Plasma Fractionation Market, For Factor Vii, By Region, 2019–2030 (Usd Billion)
Table 11 Global Plasma Fractionation Market, For Factor Viii (Von Willebrand Factor), By Region, 2019–2030 (Usd Billion)
Table 12 Global Plasma Fractionation Market, For Factor Ix, By Region, 2019–2030 (Usd Billion)
Table 13 Global Plasma Fractionation Market, For Prothrombin Complex Concentrate, By Region, 2019–2030 (Usd Billion)
Table 14 Global Plasma Fractionation Market, For Fibrinogen Concentrates, By Region, 2019–2030 (Usd Billion)
Table 15 Global Plasma Fractionation Market, For Factor Xiii, By Region, 2019–2030 (Usd Billion)
Table 16 Global Plasma Fractionation Market, For C Albumin, By Region, 2019–2030 (Usd Billion)
Table 17 Global Plasma Fractionation Market, For Protease Inhibitors, By Region, 2019–2030 (Usd Billion)
Table 18 Global Plasma Fractionation Market, For Others, By Region, 2019–2030 (Usd Billion)
Table 19 Global Plasma Fractionation Market, By Method, 2019–2030 (Usd Billion)
Table 20 Global Plasma Fractionation Market, For Cryoprecipitation, By Region, 2019–2030 (Usd Billion)
Table 21 Global Plasma Fractionation Market, For Chromatography, By Region, 2019–2030 (Usd Billion)
Table 22 Global Plasma Fractionation Market, For Ethanol Precipitation, By Region, 2019–2030 (Usd Billion)
Table 23 Global Plasma Fractionation Market, For Ultrafiltration, By Region, 2019–2030 (Usd Billion)
Table 24 Global Plasma Fractionation Market, For Others, By Region, 2019–2030 (Usd Billion)
Table 25 Global Plasma Fractionation Market, By Application, 2019–2030 (Usd Billion)
Table 26 Global Plasma Fractionation Market, For Immunology, By Region, 2019–2030 (Usd Billion)
Table 27 Global Plasma Fractionation Market, For Neurology, By Region, 2019–2030 (Usd Billion)
Table 28 Global Plasma Fractionation Market, For Hematology, By Region, 2019–2030 (Usd Billion)
Table 29 Global Plasma Fractionation Market, For Critical Care, By Region, 2019–2030 (Usd Billion)
Table 30 Global Plasma Fractionation Market, For Pulmonology, By Region, 2019–2030 (Usd Billion)
Table 31 Global Plasma Fractionation Market, For Rheumatology, By Region, 2019–2030 (Usd Billion)
Table 32 Global Plasma Fractionation Market, For Oncology, By Region, 2019–2030 (Usd Billion)
Table 33 Global Plasma Fractionation Market, For Others, By Region, 2019–2030 (Usd Billion)
Table 34 Global Plasma Fractionation Market, By End User, 2019–2030 (Usd Billion)
Table 35 Global Plasma Fractionation Market, For Hospitals & Clinics, By Region, 2019–2030 (Usd Billion)
Table 36 Global Plasma Fractionation Market, For Clinical Research Laboratories, By Region, 2019–2030 (Usd Billion)
Table 37 Global Plasma Fractionation Market, For Academic Institutes, By Region, 2019–2030 (Usd Billion)
Table 38 Global Plasma Fractionation Market, For Others, By Region, 2019–2030 (Usd Billion)
Table 39 Global: Plasma Fractionation Market, By Region, 2019–2030 (Usd Billion)
Table 40 North America: Plasma Fractionation Market, By Country, 2019–2030 (Usd Billion)
Table 41 North America: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 42 North America: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 43 North America: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 44 North America: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 45 North America: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 46 North America: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 47 Us: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 48 Us: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 49 Us: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 50 Us: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 51 Us: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 52 Us: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 53 Canada: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 54 Canada: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 55 Canada: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 56 Canada: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 57 Canada: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 58 Canada: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 59 Europe: Plasma Fractionation Market, By Country, 2019–2030 (Usd Billion)
Table 60 Europe: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 61 Europe: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 62 Europe: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 63 Europe: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 64 Europe: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 65 Europe: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 66 Germany: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 67 Germany: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 68 Germany: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 69 Germany: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 70 Germany: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 71 Germany: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 72 France: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 73 France: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 74 France: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 75 France: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 76 France: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 77 France: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 78 Uk: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 79 Uk: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 80 Uk: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 81 Uk: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 82 Uk: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 83 Uk: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 84 Italy: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 85 Italy: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 86 Italy: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 87 Italy: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 88 Italy: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 89 Italy: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 90 Spain: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 91 Spain: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 92 Spain: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 93 Spain: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 94 Spain: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 95 Spain: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 96 Belgium: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 97 Belgium: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 98 Belgium: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 99 Belgium: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 100 Belgium: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 101 Belgium: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 102 Rest Of Europe: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 103 Rest Of Europe: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 104 Rest Of Europe: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 105 Rest Of Europe: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 106 Rest Of Europe: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 107 Rest Of Europe: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 108 Asia-pacific: Plasma Fractionation Market, By Country, 2019–2030 (Usd Billion)
Table 109 Asia-pacific: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 110 Asia-pacific: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 111 Asia-pacific: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 112 Asia-pacific: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 113 Asia-pacific: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 114 Asia-pacific: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 115 China: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 116 China: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 117 China: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 118 China: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 119 China: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 120 China: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 121 India: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 122 India: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 123 India: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 124 India: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 125 India: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 126 India: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 127 Japan: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 128 Japan: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 129 Japan: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 130 Japan: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 131 Japan: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 132 Japan: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 133 South Korea: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 134 South Korea: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 135 South Korea: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 136 South Korea: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 137 South Korea: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 138 South Korea: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 139 Australia: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 140 Australia: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 141 Australia: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 142 Australia: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 143 Australia: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 144 Australia: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 145 Rest Of Asia-pacific: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 146 Rest Of Asia-pacific: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 147 Rest Of Asia-pacific: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 148 Rest Of Asia-pacific: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 149 Rest Of Asia-pacific: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 150 Rest Of Asia-pacific: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 151 Rest Ot The World: Plasma Fractionation Market, By Region, 2019–2030 (Usd Billion)
Table 152 Rest Of The World: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 153 Rest Of The World: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 154 Rest Of The World: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 155 Rest Of The World: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 156 Rest Of The World: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 157 Rest Of The World: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 158 Middle East: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 159 Middle East: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 160 Middle East: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 161 Middle East: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 162 Middle East: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 163 Middle East: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 164 Africa: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 165 Africa: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 166 Africa: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 167 Africa: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 168 Africa: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 169 Africa: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 170 Latin America: Plasma Fractionation Market, By Product, 2019–2030 (Usd Billion)
Table 171 Latin America: Plasma Fractionation Market, For Immunoglobulins, By Type, 2019–2030 (Usd Billion)
Table 172 Latin America: Plasma Fractionation Market, For Coagulation Factor Concentrates, By Type, 2019–2030 (Usd Billion)
Table 173 Latin America: Plasma Fractionation Market By Method, 2019–2030 (Usd Billion)
Table 174 Latin America: Plasma Fractionation Market By Application, 2019–2030 (Usd Billion)
Table 175 Latin America: Plasma Fractionation Market By End User, 2019–2030 (Usd Billion)
Table 176 Major Players In The Global Plasma Fractionation Market
Table 177 Benchmarking Of Major Competitors
Table 178 Most Active Player In The Global Plasma Fractionation Market
Table 179 Product Approval
Table 180 Acquisition
Table 181 Expansion
Table 182 Pfizer, Inc: Products Offered
Table 183 Pfizer, Inc.: Key Developments
Table 184 Bio Products Laboratory Ltd: Products Offered
Table 185 Kedrion S.P.A: Products Offered
Table 186 Kedrion S.P.A: Key Developments
Table 187 Adma Biologics, Inc: Products Offered
Table 188 Adma Biologics, Inc: Key Developments
Table 189 Japan Blood Products Organization: Products Offered
Table 190 Grifols, S.A.: Products Offered
Table 191 Grifols, S.A.: Key Developments
Table 192 Takeda Pharmaceutical Company Limited: Products Offered
Table 193 Takeda Pharmaceutical Company Limited: Key Developments
Table 194 Csl: Products Offered
Table 195 Csl: Key Developments
Table 196 Octapharma Ag: Products Offered
Table 197 Octapharma Ag: Key Developments
Table 198 Km Biologics: Products Offered
List Of Figures
Figure 1 Bottom-up And Top-down Approaches
Figure 2 Market Dynamics: Global Plasma Fractionation Market
Figure 3 Driver Impact Analysis
Figure 4 Restraint Impact Analysis
Figure 5 Value Chain Analysis Of The Global Plasma Fractionation Market
Figure 6 Porter’s Five Forces Analysis: Global Plasma Fractionation Market
Figure 7 Global Plasma Fractionation Market, Product Segment Attractiveness, 2019-2030 (Usd Billion)
Figure 8 Global Plasma Fractionation Market, By Product, 2024 & 2030 (Usd Billion)
Figure 9 Global Plasma Fractionation Market Share (%), By Product, 2
Figure 10 Global Plasma Fractionation Market, Method Segment Attractiveness, 2019-2030 (Usd Billion)
Figure 11 Global Plasma Fractionation Market, By Method, 2024 & 2030 (Usd Billion)
Figure 12 Global Plasma Fractionation Market Share (%), By Method, 2
Figure 13 Global Plasma Fractionation Market, Application Segment Attractiveness, 2019-2030 (Usd Billion)
Figure 14 Global Plasma Fractionation Market, By Application, 2024 & 2030 (Usd Billion)
Figure 15 Global Plasma Fractionation Market Share (%), By Application, 2
Figure 16 Global Plasma Fractionation Market, End User Segment Attractiveness, 2019-2030 (Usd Billion)
Figure 17 Global Plasma Fractionation Market, By End User, 2024 & 2030 (Usd Billion)
Figure 18 Global Plasma Fractionation Market Share (%), By End User, 2
Figure 19 Global: Plasma Fractionation Market, By Region, 2024 & 2030 (Usd Billion)
Figure 20 Global: Plasma Fractionation Market Share (%), By Region, 2
Figure 21 North America Market Analysis: Plasma Fractionation Market, 2019-2030 (Usd Billion)
Figure 22 North America: Plasma Fractionation Market, By Country, 2024 & 2030 (Usd Billion)
Figure 23 North America: Plasma Fractionation Market Share (%), By Country, 2
Figure 24 Europe Market Analysis: Plasma Fractionation Market, 2019-2030 (Usd Billion)
Figure 25 Europe: Plasma Fractionation Market, By Country, 2024 & 2030 (Usd Billion)
Figure 26 Europe: Plasma Fractionation Market Share (%), By Country, 2
Figure 27 Asia-pacific Market Analysis: Plasma Fractionation Market, 2019-2030 (Usd Billion)
Figure 28 Asia-pacific: Plasma Fractionation Market, By Country, 2024 & 2030 (Usd Billion)
Figure 29 Asia-pacific: Plasma Fractionation Market Share (%), By Country, 2
Figure 30 Rest Of The World Market Analysis: Plasma Fractionation Market, 2019-2030 (Usd Billion)
Figure 31 Rest Ot The World: Plasma Fractionation Market, By Region, 2024 & 2030 (Usd Billion)
Figure 32 Rest Ot The World: Plasma Fractionation Market Share (%), By Region, 2
Figure 33 Major Strategy Adopted By Key Players In The Global Plasma Fractionation Market
Figure 34 Global Plasma Fractionation Market: Competitive Landscape
Figure 35 Major Players Sales (Usd Billion), 2
Figure 36 Major Player R&D Expenditure (Usd Billion), 2
Figure 37 Pfizer, Inc: Financial Overview Snapshot
Figure 38 Pfizer, Inc: Financial Overview Snapshot
Figure 39 Kedrion S.P.A: Financial Overview Snapshot
Figure 40 Adma Biologics, Inc: Financial Overview Snapshot
Figure 41 Grifols, S.A.:financial Overview Snapshot
Figure 42 Grifols, S.A.: Swot Analysis
Figure 43 Takeda Pharmaceutical Company Limited: Financial Overview Snapshot
Figure 44 Takeda Pharmaceutical Company Limited: Swot Analysis
Figure 45 Csl: Financial Overview Snapshot
Figure 46 Csl: Swot Analysis
Figure 47 Octapharma Ag: Financial Overview Snapshot
Figure 48 Octapharma Ag: Swot Analysis

$4,950
$5,950
$7,250

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings